The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called flat on mixed news from China

Wed, 07th Dec 2022 07:53

(Alliance News) - Stocks in London were set to start flat on Wednesday, as weak economic data from China pointed to a "deep malaise" in the global economy, though this was offset by news that Asia's largest economy will loosen its strict zero-Covid measures.

"Having seen another lacklustre and negative session for European and US markets yesterday, there appears very little interest to drive markets higher in the short term, as we look ahead to next week's central bank meetings from the Federal Reserve, as well as the European Central Bank and Bank of England," said CMC Markets' Michael Hewson.

UK house prices fell in November from October, as the rate of annual growth slowed to 4.7% from 8.2% in October, new figures from Halifax showed.

House prices fell by 2.3% in November from October, compared to a slip of 0.4% in October from September.

"While a market slowdown was expected given the known economic headwinds – and following such extensive house price inflation over the last few years (up 19% since March 2020) – this month's fall reflects the worst of the market volatility over recent months," said Halifax Director Kim Kinnaird.

The price of a typical UK property now stands at GBP285,579, down from GBP292,406 in October.

Meanwhile, China announced a nationwide loosening of Covid restrictions, following protests against the hardline strategy that grew into calls for greater political freedoms.

Under the new guidelines, some asymptomatic and mild cases of Covid-19 can now quarantine at home, ending a requirement that all positive cases be isolated in centralised government facilities. 

This comes as official figures showed China's imports and exports plunged in November to levels not seen since early 2020.

Beijing's zero-Covid policy of snap lockdowns, travel curbs and daily mass testing has left businesses reeling, disrupted supply chains and damped consumption. 

November imports fell 11% year-on-year, the biggest collapse since May 2020. Exports fell by 8.7% year-on-year, the biggest drop since February 2020, when the country was mired in the early stages of the pandemic. 

"Recent economic numbers...point to a deep malaise, not only in the Chinese economy but also more globally," Hewson said.

"Even as the Chinese economy has underperformed domestically, the exports part of the equation had until recently been performing well. Unfortunately, even here we are now starting to see weakness as global consumers cut back on higher prices, and a weaker economic outlook," he explained.

Amid concerns about global demand, the price of Brent oil fell below USD80 for the first time since Russia's invasion of Ukraine.

Here is what you need to know ahead of the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.8 points at 7,520.59

----------

Hang Seng: down 1.2% at 19,208.76

Nikkei 225: closed down 0.7% at 27,686.40

S&P/ASX 200: closed down 0.9% at 7,229.40

----------

DJIA: closed down 350.76 points, 1.0%, at 33,596.34

S&P 500: closed down 1.4% at 3,941.26

Nasdaq Composite: closed down 2.0% at 11,014.89

----------

EUR: down at USD1.0451 (USD1.0519)

GBP: soft at USD1.2112 (USD1.2243)

USD: up at JPY137.77 (JPY136.46)

GOLD: lower at USD1,772.28 per ounce (USD1,774.71)

OIL (Brent): down at USD79.50 a barrel (USD80.35)

(changes since previous London equities close)

----------

ECONOMICS

----------

Wednesday's key economic events still to come:

11:00 CET EU gross domestic product

11:00 CET EU employment

11:00 GMT Ireland industrial production and turnover

09:30 GMT UK narrow money and reserve balances

07:00 EST US MBA mortgage applications survey

15:00 EST US consumer credit

----------

US President Joe Biden celebrated the strengthening of his party's majority in the Senate, after Democrat Raphael Warnock was declared the winner of a runoff election in Georgia. The incumbent senator defeated Republican Herschel Walker, a former football star and protege of former president Donald Trump, according to projections by television networks. Warnock's win confirms the very slim Democratic majority – 51 to 49 – in the upper house of Congress. The party's electoral triumph does not change the balance of power in the Senate, of which Democrats had already secured control on November 8. But the win by Warnock hands Democrats greater control in committees and curbs the power of any individual Democratic senator to sink Biden initiatives.

----------

German industrial production was largely stagnant in October, according to the latest figures from Destatis. Industrial production edged down 0.1% on a monthly basis in October, and remained flat on an annual basis. In September, it had increased 1.1% on a monthly basis and by 3.1% on an annual basis. Excluding energy and construction, industrial production was down by 0.4% in October from the month before but up 0.8% on an annual basis.

----------

BROKER RATING CHANGES

----------

Barclays raises Haleon to 'overweight' (equal weight) - price target 360 (298) pence

----------

JPMorgan places SGS and RS Group on 'negative catalyst watch'

----------

JPMorgan cuts Johnson Matthey to 'underweight' (neutral) - price target 2,000 (2,150) pence

----------

COMPANIES - FTSE 100

----------

GSK welcomed a US verdict in a lawsuit which had claimed the Zantac heartburn drug caused cancer. The Florida lawsuit featured roughly 50,000 claims. However, the court said plaintiffs failed to provide enough "admissible primary evidence". "In a products liability multi-district litigation, the plaintiff must have admissible primary evidence with which to establish general causation," a statement read. "As a result, if the plaintiff does not have this evidence, then there is no genuine dispute of material fact, and the defendant is entitled to judgment as a matter of law." In response, GSK said: "GSK welcomes yesterday's ruling by the MDL Court. Following the 12 epidemiological studies conducted looking at human data regarding the use of ranitidine, the scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer."

----------

COMPANIES - FTSE 250

----------

Mitchells & Butlers reported annual pretax profit of GBP8 million in the year to September 24, swung from a loss of GBP42 million the year before. "Excluding the impact of utilities, profits broadly recovered to pre Covid-19 levels," the pub chain said. Revenue more than doubled to GBP2.21 billion from GBP1.07 billion. Whilst noting a "highly challenging" trading environment, Chief Executive Phil Urban said he is encouraged by the strength of sales growth at the end of the financial year, which has since improved further.

----------

Commercial vehicle rental provider Redde Northgate reported strong growth in its first half ended October 31. Revenue rose 14% year-on-year to GBP696.3 million from GBP612.9 million, as growth in vehicle hires and claims & services offset a decline in vehicle sales. Pretax profit jumped 42% to GBP101.9 million from GBP71.7 million. The firm's interim dividend of 7.5 pence per share marks a 25% increase. "Demand for our services continues to be robust across geographies along with continuing strength in residual values," the Redde Northgate said. It now expects its full-year results to be "modestly above" market expectations.

----------

Games Workshop said trading since September has been in line with expectations. For its first half ended November 27, it expects revenue of no less than GBP210 million, compared to GBP191.5 million a year before. Pretax profit is estimated at no less than GBP83 million, down from GBP88.2 million in the prior year. The wargames maker will pay out GBP1,500 cash to each of its employees this month, as part of its profit share scheme. It also announced the promotion of John Brewis to non-executive chair. Brewis has been senior independent director since 2021, and his new role becomes effective on January 1.

----------

OTHER COMPANIES

----------

Seed Innovations said the unit holders of portfolio company Fralis - which trades as Leap - have agreed to sell Leap to an existing unit holder IMG Arena US, based on an enterprise value of EUR14 million. IMG will become the sole owner of Leap after the transaction. Seed expects to receive around EUR5.6 million in cash over a two-year period, as well as the repayment of a EUR250,000 term loan plus interest. The expected total blended return on investment over all the Leap investments is "disappointing" at 4%, Seed noted. "It is not the exit we envisaged but provides liquidity and enables Seed to continue to refocus our investment portfolio whilst at the same time setting Leap up for further success in the future," said CEO Ed McDermott.

----------

By Elizabeth Winter, senior markets reporter

 

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.